109 related articles for article (PubMed ID: 2848634)
21. [Significance of CEA in sputum in examination of lung cancer].
Muraoka H; Katoh H; Moriya H; Kimura K; Higuchi Y
Rinsho Hoshasen; 1985 Mar; 30(3):379-84. PubMed ID: 2991629
[No Abstract] [Full Text] [Related]
22. [Immunogenic activity of the regional lymphoreticulum during primary cancer of the lung].
Lenzini L; Barnabé R
Folia Allergol (Roma); 1969; 16(6):524-34. PubMed ID: 5401365
[No Abstract] [Full Text] [Related]
23. [Clinical studies of idiopathic interstitial pneumonia associated with lung cancer].
Kohno N; Takami S; Kamitsuna A; Ohnari K; Yamakido M; Nishimoto Y; Tsukiyama F
Nihon Naika Gakkai Zasshi; 1983 Dec; 72(12):1731-9. PubMed ID: 6327859
[No Abstract] [Full Text] [Related]
24. [Changes in lymphocyte subsets in the peripheral blood of patients with lung cancer during radiotherapy--analysis with flow-cytometry. (2. On the changes with the effects of radiotherapy].
Inomata T; Ogawa Y; Maeda T
Nihon Gan Chiryo Gakkai Shi; 1984 Jun; 19(5):1068-78. PubMed ID: 6334125
[No Abstract] [Full Text] [Related]
25. [Humoral leukocyte adherence inhibition test in lung cancer].
Wei HM
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1985 Feb; 8(1):25-7, 61. PubMed ID: 2986918
[No Abstract] [Full Text] [Related]
26. [Evaluation of the immunologic system in patients with small cell and squamous cell lung cancer during the early stage of treatment].
Janicka G; Chyczewska E; Przylipiak M; Kowal E
Pol Tyg Lek; 1985 Aug; 40(34):963-6. PubMed ID: 2999734
[No Abstract] [Full Text] [Related]
27. [Changes in lymphocyte subsets in the peripheral blood of patients with lung cancer during radiotherapy--analysis with flow-cytometry. (1. On the total changes].
Inomata T; Ogawa Y; Maeda T
Nihon Gan Chiryo Gakkai Shi; 1984 Jun; 19(5):1055-67. PubMed ID: 6334124
[No Abstract] [Full Text] [Related]
28. Immunocomplexes and primary lung cancer.
Lenzini L; Rottoli L; Sestini P; Carriero G; Sani G; Gotti G
Allergol Immunopathol (Madr); 1981; 9(2):119-22. PubMed ID: 6270995
[TBL] [Abstract][Full Text] [Related]
29. [Immunologic status in lung cancer].
Briusov PG; Polovoĭ AM
Sov Med; 1983; (3):16-9. PubMed ID: 6857368
[No Abstract] [Full Text] [Related]
30. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
Hadjipetrou-Kourounakis L; Tsougranis A
Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
[TBL] [Abstract][Full Text] [Related]
31. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
[TBL] [Abstract][Full Text] [Related]
32. HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer.
Seki N; Hoshino T; Kikuchi M; Hayashi A; Itoh K
Cell Immunol; 1997 Feb; 175(2):101-10. PubMed ID: 9023415
[TBL] [Abstract][Full Text] [Related]
33. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
Zeng L
Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
[TBL] [Abstract][Full Text] [Related]
34. [An evaluation of carcinoembryonic antigen (CEA), beta 2-microglobulin (BMG), and immunosuppressive acidic protein (IAP) in the serum of primary lung cancer patients].
Higuchi Y
Gan No Rinsho; 1986 Jan; 32(1):33-40. PubMed ID: 3005690
[TBL] [Abstract][Full Text] [Related]
35. [Immunological aspects of lung cancer].
Miquel Muse I; Klempert H; Mazzara R; Rodrĩguez Villamil J; Allo G; Korc I
Torax; 1970 Dec; 19(4):222-31. PubMed ID: 5520152
[No Abstract] [Full Text] [Related]
36. Failure of cell-mediated effector mechanisms in lung cancer.
Feo Figarella E; Morillo F; Blanca I; Bianco NE
J Natl Cancer Inst; 1984 Jul; 73(1):1-6. PubMed ID: 6330420
[TBL] [Abstract][Full Text] [Related]
37. [Circulating immunocomplexes in lung neoplasms].
Pesek M; Sefrna F; Simecek C; Racek J
Vnitr Lek; 1982 Jun; 28(6):571-6. PubMed ID: 6287725
[No Abstract] [Full Text] [Related]
38. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
39. [Identification of T lymphocytes in resected lung tissue in primary bronchial cancer].
Grubek-Jaworska H; Olechnowicz H; Szymańska
Pneumonol Pol; 1984 Mar; 52(3):105-10. PubMed ID: 6610173
[No Abstract] [Full Text] [Related]
40. Carcinoembryonic antigen fraction in lung cancer.
Fong S; Leon V; Betancourt M; Guarnaluse R
Neoplasma; 1983; 30(4):449-55. PubMed ID: 6310423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
